UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 146.036
NA - Nord America 10.527
AS - Asia 1.375
AF - Africa 21
SA - Sud America 20
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 157.989
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 143.317
US - Stati Uniti d'America 10.490
UA - Ucraina 969
CN - Cina 849
SE - Svezia 626
GB - Regno Unito 381
SG - Singapore 273
FI - Finlandia 260
DE - Germania 232
FR - Francia 110
IN - India 94
VN - Vietnam 66
RU - Federazione Russa 57
CA - Canada 34
KR - Corea 26
BE - Belgio 21
NL - Olanda 15
HK - Hong Kong 13
ES - Italia 12
IL - Israele 12
MU - Mauritius 12
JP - Giappone 11
BR - Brasile 10
KZ - Kazakistan 10
CL - Cile 6
PL - Polonia 6
AU - Australia 5
HU - Ungheria 5
IE - Irlanda 5
IQ - Iraq 5
NG - Nigeria 4
CZ - Repubblica Ceca 3
EU - Europa 3
LB - Libano 3
AT - Austria 2
CH - Svizzera 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
SN - Senegal 2
TW - Taiwan 2
AR - Argentina 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
KW - Kuwait 1
LK - Sri Lanka 1
MC - Monaco 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VE - Venezuela 1
Totale 157.989
Salva come PNG Salva come JPEG
Città #
Cagliari 136.983
Uta 5.797
Fairfield 1.226
Woodbridge 1.039
Houston 1.035
Chandler 978
Boardman 735
Ashburn 708
Ann Arbor 538
Wilmington 521
Jacksonville 518
Seattle 498
Cambridge 465
Nyköping 353
Nanjing 184
Boston 169
Singapore 152
Dearborn 131
Beijing 110
Santa Clara 109
San Diego 99
Helsinki 97
Shanghai 84
Milan 79
Dong Ket 66
Nanchang 57
Mountain View 56
Redwood City 52
Shenyang 52
Verona 52
Jiaxing 49
Ferrara 45
Rome 42
London 40
Hebei 38
Los Angeles 38
Washington 37
Pune 36
Falls Church 35
Guangzhou 35
Changsha 34
Norwalk 34
Tianjin 31
Sassari 28
Orange 26
New York 25
Jinan 21
Saint Petersburg 21
Seoul 21
Toronto 21
Ningbo 20
Paris 19
Olbia 17
Brussels 15
Tappahannock 13
Zhengzhou 12
Atlanta 11
Auburn Hills 11
Borås 11
Chicago 11
Indiana 11
Phoenix 11
Renton 11
Astana 10
Taizhou 10
Azor 9
Kilburn 9
Cedar Knolls 8
Central 8
Chapel Hill 8
Hefei 8
Wuhan 8
Champaign 7
Hangzhou 7
Hounslow 7
Munich 7
San Francisco 7
San Mateo 7
La Canada Flintridge 6
Naples 6
Budapest 5
Dublin 5
Far Rockaway 5
Frankfurt am Main 5
Fuzhou 5
Jinhua 5
Saint Louis 5
Villanovafranca 5
Wuxi 5
Barcelona 4
Chengdu 4
Chiswick 4
Clifton 4
Council Bluffs 4
Giarre 4
Nürnberg 4
Stabroek 4
Stockholm 4
Wandsworth 4
Augusta 3
Totale 153.993
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.743
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.727
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.695
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.673
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.593
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.581
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.478
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.475
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.472
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.452
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.406
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.374
Critical role for prokineticin 2 in CNS autoimmunity 2.305
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.239
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.195
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.141
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.139
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.136
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.062
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 1.990
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 1.964
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 1.943
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 1.932
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 1.896
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 1.826
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.777
null 1.768
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.766
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.716
An important role for prokineticin 2 in autoimmune CNS demyelination 1.694
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.613
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.578
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.541
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.503
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.475
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.436
null 1.383
null 1.379
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.373
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.371
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.326
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.299
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.265
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.263
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.209
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.207
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.184
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.163
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.155
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.125
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.074
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 1.047
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 1.026
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 1.009
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 966
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 937
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 881
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 828
null 825
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 791
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 786
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 778
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 758
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 757
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 752
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 750
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 736
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 734
null 731
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 701
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 656
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 653
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 637
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 628
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 615
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 610
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 608
Hair Growth Promotion by δ-Opioid Receptor Activation 603
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 570
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 563
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 557
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 555
null 546
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 539
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 538
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 538
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 526
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 521
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 510
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 480
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 477
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 468
Synthesis of N-FmocN,N'-bis-Boc-5-,6- and 8-guanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid (5-GTIC, 6-GTIC and 8-GTIC) 463
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 461
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 452
A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress 448
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 438
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated 438
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 434
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 434
Totale 125.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018.961 0 0 0 0 7.484 5.154 2.809 719 645 594 579 977
2020/202130.722 1.251 938 1.418 7.715 5.734 3.390 2.804 1.789 791 1.628 1.745 1.519
2021/20229.546 600 806 1.092 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202531.589 8.850 11.727 5.085 4.291 1.636 0 0 0 0 0 0 0
Totale 158.561